First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 10.17 USD 4.2% Market Closed
Updated: Jul 27, 2024
Have any thoughts about
Atara Biotherapeutics Inc?
Write Note

Wall Street
Price Targets

ATRA Price Targets Summary
Atara Biotherapeutics Inc

There are no price targets for ATRA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Atara Biotherapeutics Inc Competitors:
Price Targets
2142
Hbm Holdings Ltd
33% Upside
LGND
Ligand Pharmaceuticals Inc
12% Upside
NGNE
Neurogene Inc
18% Upside
LYEL
Lyell Immunopharma Inc
128% Upside
301047
Sino Biological Inc
67% Upside
NRBO
Neurobo Pharmaceuticals Inc
567% Upside
HPHA
Heidelberg Pharma AG
337% Upside
FOLD
Amicus Therapeutics Inc
74% Upside

Revenue
Forecast

Revenue Estimate
Atara Biotherapeutics Inc

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 3 years is 124%.

N/A
Past Growth
124%
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRA's stock price target?
Not Available

ATRA doesn't have any price targets made by Wall Street professionals.

What is Atara Biotherapeutics Inc's Revenue forecast?
Projected CAGR
124%

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 3 years is 124%.